174 related articles for article (PubMed ID: 23058107)
1. Synthesis and structure-activity relationship of berberine analogues in LDLR up-regulation and AMPK activation.
Wang YX; Kong WJ; Li YH; Tang S; Li Z; Li YB; Shan YQ; Bi CW; Jiang JD; Song DQ
Bioorg Med Chem; 2012 Nov; 20(22):6552-8. PubMed ID: 23058107
[TBL] [Abstract][Full Text] [Related]
2. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor.
Wang YX; Wang YP; Zhang H; Kong WJ; Li YH; Liu F; Gao RM; Liu T; Jiang JD; Song DQ
Bioorg Med Chem Lett; 2009 Nov; 19(21):6004-8. PubMed ID: 19800225
[TBL] [Abstract][Full Text] [Related]
4. Berberine metabolites exhibit triglyceride-lowering effects via activation of AMP-activated protein kinase in Hep G2 cells.
Cao S; Zhou Y; Xu P; Wang Y; Yan J; Bin W; Qiu F; Kang N
J Ethnopharmacol; 2013 Sep; 149(2):576-82. PubMed ID: 23899453
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of berberine analogues as a novel class of low-density-lipoprotein receptor up-regulators.
Yang P; Song DQ; Li YH; Kong WJ; Wang YX; Gao LM; Liu SY; Cao RQ; Jiang JD
Bioorg Med Chem Lett; 2008 Aug; 18(16):4675-7. PubMed ID: 18644725
[TBL] [Abstract][Full Text] [Related]
6. Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy.
Li YH; Yang P; Kong WJ; Wang YX; Hu CQ; Zuo ZY; Wang YM; Gao H; Gao LM; Feng YC; Du NN; Liu Y; Song DQ; Jiang JD
J Med Chem; 2009 Jan; 52(2):492-501. PubMed ID: 19090767
[TBL] [Abstract][Full Text] [Related]
7. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
Turner N; Li JY; Gosby A; To SW; Cheng Z; Miyoshi H; Taketo MM; Cooney GJ; Kraegen EW; James DE; Hu LH; Li J; Ye JM
Diabetes; 2008 May; 57(5):1414-8. PubMed ID: 18285556
[TBL] [Abstract][Full Text] [Related]
8. Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes.
Li Y; Ren G; Wang YX; Kong WJ; Yang P; Wang YM; Li YH; Yi H; Li ZR; Song DQ; Jiang JD
J Transl Med; 2011 May; 9():62. PubMed ID: 21569619
[TBL] [Abstract][Full Text] [Related]
9. Berberine up-regulates hepatic low-density lipoprotein receptor through Ras-independent but AMP-activated protein kinase-dependent Raf-1 activation.
Li Z; Jiang JD; Kong WJ
Biol Pharm Bull; 2014; 37(11):1766-75. PubMed ID: 25196457
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins.
Yashiro T; Nanmoku M; Shimizu M; Inoue J; Sato R
Atherosclerosis; 2012 Feb; 220(2):369-74. PubMed ID: 22153697
[TBL] [Abstract][Full Text] [Related]
11. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine.
Abidi P; Zhou Y; Jiang JD; Liu J
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2170-6. PubMed ID: 16100034
[TBL] [Abstract][Full Text] [Related]
12. Combination of simvastatin with berberine improves the lipid-lowering efficacy.
Kong WJ; Wei J; Zuo ZY; Wang YM; Song DQ; You XF; Zhao LX; Pan HN; Jiang JD
Metabolism; 2008 Aug; 57(8):1029-37. PubMed ID: 18640378
[TBL] [Abstract][Full Text] [Related]
13. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.
Kong W; Wei J; Abidi P; Lin M; Inaba S; Li C; Wang Y; Wang Z; Si S; Pan H; Wang S; Wu J; Wang Y; Li Z; Liu J; Jiang JD
Nat Med; 2004 Dec; 10(12):1344-51. PubMed ID: 15531889
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase.
Li J; Pan Y; Kan M; Xiao X; Wang Y; Guan F; Zhang X; Chen L
Life Sci; 2014 Mar; 98(1):24-30. PubMed ID: 24412384
[TBL] [Abstract][Full Text] [Related]
15. Berberine-induced activation of 5'-adenosine monophosphate-activated protein kinase and glucose transport in rat skeletal muscles.
Ma X; Egawa T; Kimura H; Karaike K; Masuda S; Iwanaka N; Hayashi T
Metabolism; 2010 Nov; 59(11):1619-27. PubMed ID: 20423742
[TBL] [Abstract][Full Text] [Related]
16. Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway.
Fan X; Wang J; Hou J; Lin C; Bensoussan A; Chang D; Liu J; Wang B
J Transl Med; 2015 Mar; 13():92. PubMed ID: 25884210
[TBL] [Abstract][Full Text] [Related]
17. 9-O-benzoyl-substituted berberine exerts a triglyceride-lowering effect through AMPK signaling pathway in human hepatoma HepG2 cells.
Cao S; Yu S; Cheng L; Yan J; Zhu Y; Deng Y; Qiu F; Kang N
Environ Toxicol Pharmacol; 2018 Dec; 64():11-17. PubMed ID: 30268048
[TBL] [Abstract][Full Text] [Related]
18. Berberine regulates neurite outgrowth through AMPK-dependent pathways by lowering energy status.
Lu J; Cao Y; Cheng K; Xu B; Wang T; Yang Q; Yang Q; Feng X; Xia Q
Exp Cell Res; 2015 Jun; 334(2):194-206. PubMed ID: 25889370
[TBL] [Abstract][Full Text] [Related]
19. Quercetin up-regulates LDL receptor expression in HepG2 cells.
Moon J; Lee SM; Do HJ; Cho Y; Chung JH; Shin MJ
Phytother Res; 2012 Nov; 26(11):1688-94. PubMed ID: 22388943
[TBL] [Abstract][Full Text] [Related]
20. Berberine suppresses proinflammatory responses through AMPK activation in macrophages.
Jeong HW; Hsu KC; Lee JW; Ham M; Huh JY; Shin HJ; Kim WS; Kim JB
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E955-64. PubMed ID: 19208854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
